Form 4 for TARA Protara Therapeutics, Inc.
Accepted 2021-11-08 00:00:00 ET · period of report 2021-11-04 · accession 0001493152-21-027485 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2021-11-08 | 2021-11-04 | TARA | Opaleye Management Inc. | 10% | P - Purchase | $6.50 | +6,557 | 2.46M | +0.3% | +$42.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.001 per share | 2021-11-04 | P | A | 557 | $6.50 | 100,557 | I By Managed Account | — | — | (F2) Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account. |
| 2 | Common | Common Stock, par value $0.001 per share | 2021-11-04 | P | A | 6,000 | $6.50 | 2,464,472 | I By Opaleye, L.P. | — | — | (F1) Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund. |